AVP and cancer: In particular, the three histotypes with higher risk of future cancer were ADH (13.6%), atypical PLs (9.7%), and LIN (8.8%); thus, in our opinion, these three categories could benefit from a tailored approach to surveillance and patients with these histotypes should not be discharged from clinical and radiological follow-up [20,21,22,23,24].